Company profile: Myocor
1.1 - Company Overview
Company description
- Provider of therapeutic cardiac technologies and evaluations to treat mitral regurgitation and heart failure, improving cardiac function. Offers the Coapsys System, a device and therapy for mitral valve insufficiency via a less invasive, off-pump, closed-heart procedure. Founded in 1996 and based in Minnesota.
Products and services
- Coapsys System: Engineers a device-therapy that treats mitral valve insufficiency via a less invasive, off-pump, closed-heart procedure for patients with mitral regurgitation
- Cardiac Technology Evaluations: Delivers cardiac-specific evaluations on technologies to treat mitral regurgitation and heart failure, supporting therapeutic development that assists improvement of cardiac function
- Therapeutic Product Development and Distribution: Develops and distributes a range of therapeutic products for clients, producing technologies that assist improvement of cardiac function and address mitral regurgitation and heart failure.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Myocor
Veryan Medical
HQ: United Kingdom
Website
- Description: Provider of three-dimensional Nitinol vascular stents for peripheral arterial disease, including the BioMimics 3D Vascular Stent System, a self-expanding stent with 3D helical geometry designed to impart a gentle helical shape to the stented artery to provoke swirling flow, increase wall shear stress, reduce intimal hyperplasia, improve biomechanical compatibility, and reduce stent fracture risk, and the MIMICS clinical program (MIMICS-RCT, MIMICS-2, MIMICS-3D) evaluating safety, effectiveness, and performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veryan Medical company profile →
OmniSonics
HQ: United States
Website
- Description: Provider of U.S.-based medical devices for the treatment of vascular occlusive diseases, with products designed to deliver transverse ultrasonic energy along the length of a small-diameter wire to arteries or veins obstructed by thrombus.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniSonics company profile →
Tactile Medical
HQ: United States
Website
- Description: Provider of at-home medical devices and therapies for edema, lymphedema, and vascular and respiratory conditions, including Flexitouch Plus and Entre pneumatic compression systems, AffloVest mobile airway clearance therapy, Complete Decongestive Therapy, and patient education on lymphedema management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tactile Medical company profile →
Lifebridge
HQ: Germany
Website
- Description: Provider of novel therapy for use by cardiologists, cardiovascular surgeons, and ER physicians to treat patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifebridge company profile →
Transcatheter Technologies
HQ: Germany
Website
- Description: Provider of a unique, repositionable transcatheter aortic valve implantation system designed to increase the safety and durability of aortic valve implantation. Its TRINITY transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transcatheter Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Myocor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Myocor
2.2 - Growth funds investing in similar companies to Myocor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Myocor
4.2 - Public trading comparable groups for Myocor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →